ロード中...
Tamoxifen inhibits cell proliferation by impaired glucose metabolism in gallbladder cancer
Gallbladder cancer (GBC) is the leading malignancy of biliary system showing refractory chemoresistance to current first‐line drugs. Growing epidemiological evidences have established that the incidence of GBC exhibits significant gender predominance with females two‐threefold higher than males, sug...
保存先:
| 出版年: | J Cell Mol Med |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6991689/ https://ncbi.nlm.nih.gov/pubmed/31782270 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.14851 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|